Targeting the translationally controlled tumor protein by a monoclonal antibody improves allergic airway inflammation in mice.

Bae, Hae-Duck; Cho, Minyoung; Seo, Hyeran; Lyoo, In Kyoon; Lee, Kyunglim

Bae, Hae-Duck; Cho, Minyoung; Seo, Hyeran; Lyoo, In Kyoon; Lee, Kyunglim.

Afiliación

Bae HD; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, the Republic of Korea.
Cho M; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, the Republic of Korea.
Seo H; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, the Republic of Korea.
Lyoo IK; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, the Republic of Korea.
Lee K; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, the Republic of Korea. Electronic address: klyoon@ewha.ac.kr.

Biomed Pharmacother ; 168: 115655, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37806090

Asunto(s)

Asma; Hipersensibilidad; Animales; Ratones; Interleucina-8/farmacología; Proteína Tumoral Controlada Traslacionalmente 1; Asma/metabolismo; Hipersensibilidad/tratamiento farmacológico; Pulmón; Inflamación/metabolismo; Citocinas/metabolismo; Líquido del Lavado Bronquioalveolar; Ovalbúmina/farmacología; Ratones Endogámicos BALB C; Modelos Animales de Enfermedad

Palabras clave

Airway inflammation; Antihistaminic drug; Histamine-releasing factor (HRF); Monoclonal antibody; Translationally controlled tumor protein (TCTP)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Asma / Hipersensibilidad Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google